Episode #60: Meet the Start-up Focused on Microbe-tech

Tech Optimist Podcast — Tech, Entrepreneurship, and Innovation

Written by

Alumni Ventures

Published on

Read

2 min

In this episode of the Alumni Ventures Tech Optimist Podcast, host Drew Wandzilak interviews Cheri Ackerman, co-founder and CEO of Concerto Biosciences, about their innovative approach to leveraging microbes for health and agriculture. Cheri discusses their kChip technology, which tests microbial combinations for effective ecosystems, and highlights their clinical trials aimed at conditions like eczema, underscoring Concerto’s vision of transforming microbes from adversaries to valuable allies in biotechnology.

Episode #60: Meet the Start-up Focused on Microbe-tech

See video policy below.

In this Meet the Startup episode of the Alumni Ventures Tech Optimist Podcast, host Drew Wandzilak, Senior Associate at Alumni Ventures, introduces Cheri Ackerman, co-founder and CEO of Concerto Biosciences. Based in Cambridge, Massachusetts, Concerto is transforming how we use microbes to develop innovative products for health, agriculture, and beyond. Cheri dives into their groundbreaking technology, kChip, which tests millions of microbial combinations to discover effective microbial ecosystems.

Watch Time ~42 minutes

The show is produced by Alumni Ventures, which has been recognized as a “Top 20 Venture Firm” by CB Insights (’24) and as the “#1 Most Active Venture Firm in the US” by Pitchbook (’22 & ’23).

READ THE FULL EPISODE TRANSCRIPT

Creators and Guests

HOST

Drew Wandzilak
Senior Associate at Alumni Ventures

Drew has worked in high-growth industries as both an investor and operator, focusing on how people and technology interact within organizations. His venture experience began at AV’s Seed Fund, identifying and supporting early stage founders across a variety of industries. This experience led him to join Holistic Industries, a leading private multi-state operator of cannabis cultivation facilities and dispensaries, where he focused on business intelligence, corporate development, and M&A. Prior to rejoining AV, he worked with the founding team of Mirage, an NFT marketplace and view layer for augmented reality assets. Drew has a BS from Northwestern University in Education and Social Policy with concentrations in Learning & Organizational Change and Entrepreneurship. He is also an ambassador of Northwestern’s Farley Center for Entrepreneurship and Innovation and a member of Chicago Inno’s 25 under 25.

GUEST

Cheri Ackerman
Co-founder & CEO at Concerto Biosciences

Cheri Ackerman is the Co-founder and CEO of Concerto Biosciences, a company revolutionizing microbial product discovery. Concerto explores the intricate relationships between microbes, uncovering insights that pave the way for groundbreaking innovations.

To Learn More

Click the logos below for more information.

Important Disclosure Information

The Tech Optimist Podcast is for informational purposes only. It is not personalized advice and is neither an offer to sell, nor a solicitation of an offer to purchase, any security. Such offers are made only to eligible investors, pursuant to the formal offering documents of appropriate investment funds. Please consult with your advisors before making any investment with Alumni Ventures. For more information, please see here.

One or more investment funds affiliated with AV may have invested, or may in the future invest, in some of the companies featured on the Podcast. This circumstance constitutes a conflict of interest. Any testimonials or endorsements regarding AV on the Podcast are made without compensation but the providers may in some cases have a relationship with AV from which they benefit. All views expressed on the Podcast are the speaker’s own. Any testimonials or endorsements expressed on the Podcast do not represent the experience of all investors or companies with which AV invests or does business.

The Podcast includes forward-looking statements, generally consisting of any statement pertaining to any issue other than historical fact, including without limitation predictions, financial projections, the anticipated results of the execution of any plan or strategy, the expectation or belief of the speaker, or other events or circumstances to exist in the future. Forward looking statements are not representations of actual fact, depend on certain assumptions that may not be realized, and are not guaranteed to occur. Any forward- looking statements included in this communication speak only as of the date of the communication. AV and its affiliates disclaim any obligation to update, amend, or alter such forward-looking statements whether due to subsequent events, new information, or otherwise.